We are live on ! Find out more
IDXX icon

Idexx Laboratories

801 hedge funds and large institutions have $24.8B invested in Idexx Laboratories in 2020 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 253 increasing their positions, 299 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 114 | Existing positions closed: 54

35% more capital invested

Capital invested by funds: $18.4B → $24.8B (+$6.36B)

22% more funds holding in top 10

Funds holding in top 10: 1822 (+4)

7% more funds holding

Funds holding: 748801 (+53)

9% less call options, than puts

Call options by funds: $53.6M | Put options by funds: $58.7M

1.04% less ownership

Funds ownership: 89.34%88.3% (-1%)

15% less repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 299

Holders
801
Holders Change
+53
Holders Change %
+7.09%
% of All Funds
16.42%
Holding in Top 10
22
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+22.22%
% of All Funds
0.45%
New
114
Increased
253
Reduced
299
Closed
54
Calls
$53.6M
Puts
$58.7M
Net Calls
-$5.09M
Net Calls Change
+$3.87M
Name Holding Trade Value Shares
Change
Change in
Stake
PS
351
Pensionfund Sabic
Netherlands
$2.25M
CAM
352
Covenant Asset Management
New Jersey
$2.21M -$20.8K -72 -1%
Fiera Capital (Canada)
353
Fiera Capital (Canada)
Quebec, Canada
$2.15M +$1.45K +5 +0.1%
FIM
354
Freedom Investment Management
Connecticut
$2.15M -$420K -1,451 -18%
Janney Montgomery Scott
355
Janney Montgomery Scott
Pennsylvania
$2.15M +$610K +2,107 +48%
II
356
IFM Investors
Australia
$2.12M -$631K -2,181 -25%
BFA
357
Brendel Financial Advisors
New Hampshire
$2.12M -$6.95K -24 -0.4%
OWP
358
Obermeyer Wealth Partners
Colorado
$2.12M +$113K +392 +7%
ZIM
359
Zacks Investment Management
Illinois
$2.1M +$36.2K +125 +2%
MIC
360
Means Investment Company
Maine
$2.07M -$51.2K -177 -3%
CWM
361
Calamos Wealth Management
Illinois
$2.05M
CCM
362
Cribstone Capital Management
Maine
$1.99M -$36.2K -125 -2%
MME
363
Meag Munich Ergo
Germany
$1.98M -$160K -551 -8%
OAM
364
Optimal Asset Management
California
$1.96M -$1.07M -3,684 -38%
PAM
365
Panagora Asset Management
Massachusetts
$1.95M -$66.9K -231 -4%
AG
366
Algert Global
California
$1.93M +$100K +347 +6%
NMERB
367
New Mexico Educational Retirement Board
New Mexico
$1.9M +$116K +400 +7%
MML Investors Services
368
MML Investors Services
Massachusetts
$1.89M +$1.08M +3,743 +188%
VRS
369
Virginia Retirement Systems
Virginia
$1.88M
RIM
370
Redpoint Investment Management
Australia
$1.86M -$115K -398 -7%
AB
371
Amalgamated Bank
New York
$1.85M -$2.47M -8,542 -60%
Bank Julius Baer & Co
372
Bank Julius Baer & Co
Switzerland
$1.85M -$694K -2,396 -30%
LIA
373
LS Investment Advisors
Michigan
$1.84M +$752K +2,597 +88%
BG
374
Berry Group
Massachusetts
$1.81M
TCM
375
Teza Capital Management
Illinois
$1.81M +$1.58M +5,472 New

IDXX Hedge Fund Activity: Q2 2020 in Review

801 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2020, worth a combined $24.8B — up 35% from $18.4B a quarter earlier.

Buyers outnumbered sellers: 114 funds opened new IDXX positions and 54 closed out — a net gain of 60 holders — while 253 added to existing stakes and 299 trimmed.

The largest buyer was Durable Capital Partners, adding an estimated $66.1M. The largest seller was Select Equity Group, cutting an estimated $119M.

  • 801 institutional investors held Idexx Laboratories (IDXX) as of Q2 2020, up from 748 in Q1 2020.
  • Funds reported $24.8B of Idexx Laboratories stock for Q2 2020, up 35% quarter-over-quarter.
  • 114 funds opened new Idexx Laboratories positions in Q2 2020 and 54 closed out, a net change of +60 holders.
  • The largest Idexx Laboratories buyer in Q2 2020 was Durable Capital Partners, an estimated $66.1M added.
  • The largest Idexx Laboratories seller in Q2 2020 was Select Equity Group, an estimated $119M sold.

Based on aggregated 13F filings for Q2 2020.